Catalyst

Slingshot members are tracking this event:

GlaxoSmithKline (GSK) Files New Drug Application in Japan for Shingrix Vaccine in the Prevention of Shingles

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GSK

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 18, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Biologics License Application, Shingrix, Vaccines, Shingles, Prevention, Herpes Zoster